Iridex Corp
IRIX- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- SEC CIK
- 0001006045
In the last 90 days, Iridex Corp insiders filed 4 open-market purchases and 0 sales; 29 institutions reported holding it in 13F filings for Q2 2026, worth $2.47M in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Iridex Corp changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 30 | 28 | −2 |
| Shares | 3.53M | 3.53M | −1.36K (0.0%) |
| Value | $9.07M | $8.51M | −$566.9K (−6.2%) |
New holders (2)
Institutions that held Iridex Corp at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Apexium Financial, LP | 65,695 | $158.0K | 0.02% |
| Royal Bank of Canada | 41 | $0 | 0.00% |
Sold out (4)
Institutions that held Iridex Corp at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Essex Investment Management Co LLC | 83,528 | $215.0K |
| Susquehanna International Group, LLP | 24,613 | $63.0K |
| Millennium Management LLC | 16,780 | $43.0K |
| Two Sigma Advisers, LP | 15,100 | $39.0K |